Table 1 Baseline characteristics

From: Effects of specialised physiotherapy on mortality in Parkinson’s disease: a prospective observational study

 

Specialised physiotherapya

(n = 13,775)

Usual care physiotherapyb

(n = 36,736)

Difference (95% CI)

P-value

Age, years (SD)

72.19 (9.92)

72.52 (9.36)

0.33 (0.13–0.52)

0.0009

Female, number (%)

5148 (37.4%)

15,940 (43.4%)

6.1% (5.11–6.98)

<0.0001

Socioeconomic status (SD)c

−0.0098 (0.97)

0.0015 (1.01)

0.01 (−0.01–0.03)

0.25

≥2 PD-specific medications, number (%)d

3142 (22.8%)

10,335 (28.1%)

5.32 (4.49–6.16)

<0.0001

Number of PD-specific complications (SD)d

0.05 (0.27)

0.07 (0.32)

0.02 (0.01–0.02)

<0.0001

Total hospital-related cost in euro (SD)d

3654.48 (6873.94)

4343.47 (8415.40)

688.99 (545.52–832.46)

<0.0001

Use of mental health care (SD)d

0.07 (0.26)

0.09 (0.29)

0.02 (0.01–0.02)

<0.0001

Use of depression medication (SD)d

0.07 (0.26)

0.08 (0.28)

0.009 (0.004–0.015)

0.0003

Total long-term care act related cost in euro (SD)d

277.36 (3939.39)

380.45 (4479.18)

103.09 (22.92–183.25)

0.01

Year of follow-up start (median)

2015

2012

 

<0.0001

  1. aSpecialised physiotherapy consists of ParkinsonNet affliliated health care professionals who work in regional community networks according to evidence based guidelines with a high caseload of persons with PD.
  2. bUsual care physiotherapy consist of non ParkinsonNet affiliated health care professionals with general training.
  3. cWe standardized socioeconomic scores, scale from –6.93 to 2.91, with lower numbers indicating a lower socioeconomic status.
  4. dCharacteristics were determined in the year prior to enrolment.